Published in Med Teach on May 07, 2014
Understanding Career Success and Its Contributing Factors for Clinical and Translational Investigators. Acad Med (2016) 1.09
Comparison of Women in Department Leadership in Obstetrics and Gynecology With Those in Other Specialties. Obstet Gynecol (2016) 0.75
Creating More Effective Mentors: Mentoring the Mentor. AIDS Behav (2016) 0.75
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
Telaprevir for previously treated chronic HCV infection. N Engl J Med (2010) 8.33
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA (2012) 7.62
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med (2008) 7.22
Effects of physician experience on costs and outcomes on an academic general medicine service: results of a trial of hospitalists. Ann Intern Med (2002) 7.09
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med (2005) 7.01
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet (2012) 6.93
Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med (2007) 6.11
Primary biliary cirrhosis. Hepatology (2009) 5.35
Patients' and physicians' attitudes regarding the disclosure of medical errors. JAMA (2003) 4.94
The Canadian C-spine rule versus the NEXUS low-risk criteria in patients with trauma. N Engl J Med (2003) 4.48
Comparison of the Canadian CT Head Rule and the New Orleans Criteria in patients with minor head injury. JAMA (2005) 4.35
Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology (2003) 4.33
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med (2003) 4.12
Histological outcome during long-term lamivudine therapy. Gastroenterology (2003) 3.88
Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med (2010) 3.83
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology (2008) 3.82
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology (2006) 3.80
A behavioral and systems view of professionalism. JAMA (2010) 3.79
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med (2007) 3.72
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med (2009) 3.70
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med (2007) 3.64
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med (2005) 3.46
The future of general internal medicine. Report and recommendations from the Society of General Internal Medicine (SGIM) Task Force on the Domain of General Internal Medicine. J Gen Intern Med (2004) 3.19
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Grounded theory, mixed methods, and action research. BMJ (2008) 3.14
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology (2004) 2.98
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology (2004) 2.97
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology (2008) 2.80
Critically appraising qualitative research. BMJ (2008) 2.68
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
Continuing medical education and quality improvement: a match made in heaven? Ann Intern Med (2012) 2.63
"Between me and the computer": increased detection of intimate partner violence using a computer questionnaire. Ann Emerg Med (2002) 2.60
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med (2011) 2.59
Teaching quality improvement and patient safety to trainees: a systematic review. Acad Med (2010) 2.44
Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42
MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol (2013) 2.37
The need for public engagement in choosing health priorities. CMAJ (2010) 2.35
An introduction to reading and appraising qualitative research. BMJ (2008) 2.27
Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol (2003) 2.25
The phagocytes: neutrophils and monocytes. Blood (2008) 2.25
"You're not a victim of domestic violence, are you?" Provider patient communication about domestic violence. Ann Intern Med (2007) 2.19
Surgeons' tone of voice: a clue to malpractice history. Surgery (2002) 2.18
Is physician self-disclosure related to patient evaluation of office visits? J Gen Intern Med (2004) 2.13
Evaluating surgeons' informed decision making skills: pilot test using a videoconferenced standardised patient. Med Educ (2003) 2.07
Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol (2005) 2.05
What do physicians tell patients about themselves? A qualitative analysis of physician self-disclosure. J Gen Intern Med (2004) 2.01
Reimagining the self at late-career transitions: how identity threat influences academic physicians' retirement considerations. Acad Med (2015) 2.00
Quality improvement in medical education: current state and future directions. Med Educ (2012) 1.97
Revalidation of physicians in Canada: are we passing the test? CMAJ (2008) 1.95
Are physicians ready for patients with Internet-based health information? J Med Internet Res (2006) 1.94
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial. Ann Intern Med (2007) 1.92
A trial of disclosing physicians' financial incentives to patients. Arch Intern Med (2006) 1.91
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology (2005) 1.89
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion (2002) 1.89
Universal health insurance and health care access for homeless persons. Am J Public Health (2010) 1.85
Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology (2013) 1.84
What does it cost physician practices to interact with health insurance plans? Health Aff (Millwood) (2009) 1.83
Disclosing harmful medical errors to patients. N Engl J Med (2007) 1.82
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology (2010) 1.80
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology (2009) 1.79
A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr (2010) 1.79
Does the public think it is reasonable to wait for more evidence before funding innovative health technologies? The case of PET scanning in Ontario. Int J Technol Assess Health Care (2010) 1.73
Choosing your words carefully: how physicians would disclose harmful medical errors to patients. Arch Intern Med (2006) 1.69
Interventions for intimate partner violence against women: clinical applications. JAMA (2003) 1.69
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology (2002) 1.69
Teaching medical error disclosure to physicians-in-training: a scoping review. Acad Med (2013) 1.69
Risk managers, physicians, and disclosure of harmful medical errors. Jt Comm J Qual Patient Saf (2010) 1.69
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol (2008) 1.69
US and Canadian physicians' attitudes and experiences regarding disclosing errors to patients. Arch Intern Med (2006) 1.68
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol (2003) 1.68
US physician practices versus Canadians: spending nearly four times as much money interacting with payers. Health Aff (Millwood) (2011) 1.64
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet (2010) 1.62
Synthesis of scientific disciplines in pursuit of health: the Interactive Biopsychosocial Model. Perspect Biol Med (2003) 1.62
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response. Hepatology (2011) 1.62
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology (2007) 1.60
Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest (2006) 1.60
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology (2002) 1.60
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J (2009) 1.59
Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatol (2005) 1.58
The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One (2012) 1.58
Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol (2003) 1.57
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int (2008) 1.56
A prescription for protecting the doctor-patient relationship. Am J Manag Care (2004) 1.56
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
Talking with patients about other clinicians' errors. N Engl J Med (2013) 1.54
The effect of traumatic brain injury on the health of homeless people. CMAJ (2008) 1.53
Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. Clin Gastroenterol Hepatol (2013) 1.53
Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J Am Geriatr Soc (2007) 1.52
Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology (2005) 1.49
How surgeons disclose medical errors to patients: a study using standardized patients. Surgery (2005) 1.49
Exploring mentorship as a strategy to build capacity for knowledge translation research and practice: protocol for a qualitative study. Implement Sci (2009) 1.48
Simulation of brain death from fulminant de-efferentation. Can J Neurol Sci (2003) 1.48
Cranial pachymeningitis: an unusual manifestation of Wegener's granulomatosis. J Rheumatol (2003) 1.47
Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology (2010) 1.47
Line sepsis in home parenteral nutrition patients: are there socioeconomic risk factors? A Canadian study. JPEN J Parenter Enteral Nutr (2005) 1.46
Dietary intake of elderly living in Toronto long-term care facilities: comparison to the dietary reference intake. Rejuvenation Res (2007) 1.46
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int (2009) 1.46